---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-028949"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2025-09-12T23:59:59+00:00"
generated_at: "2026-05-17T06:45:14.965678+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NRx subsidiary HOPE Therapeutics completes acquisition of Dura Medical

## Summary
- Dura Medical is revenue generating and EBITDA positive; operates clinics in Naples and Ft. Myers.
- Offers ketamine therapy, TMS, Spravato, stellate ganglion blocks for depression and PTSD.
- Participates in VA Community Cares Network; founder Stephen Durand appointed Director of Florida Clinic Operations.
- Combined with pending acquisitions to provide coverage at more than 8 locations on Florida's West Coast.

## SEC filing metadata
- accession: 0001437749-25-028949
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2025-09-12T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000143774925028949/0001437749-25-028949-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000143774925028949/nrxp20250912_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-028949
- JSON: https://secwatch.observer/filing/0001437749-25-028949.json
- Plain text: https://secwatch.observer/filing/0001437749-25-028949.txt

## Key facts
- M&A Transactions
  NRX Pharmaceuticals, Inc. completed an acquisition involving Dura Medical, LLC for a combination of cash, membership interests in HTX Management Company LLC (which are convertible into shares of Hope Therapeutics on a one-for-one basis at the (closed 2025-09-08).
  - Action: acquisition
  - Counterparty: Dura Medical, LLC
  - Consideration: a combination of cash, membership interests in HTX Management Company LLC (which are convertible into shares of Hope Therapeutics on a one-for-one basis at the
  - Closing: 2025-09-08
  source text: On September 8, 2025, NRx Pharmaceuticals (NASDAQ: NRXP, or the “Company”), principally through its subsidiary HOPE Therapeutics, Inc., a Delaware corporation, completed its previously announced acquisition of Dura Medical, LLC
  evidence_url: https://www.sec.gov/Archives/edgar/data/1719406/000143774925028949/0001437749-25-028949-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.